Trade AbbVie ABBV

Sell
 Buy

AbbVie live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

AbbVie News

Ava Grace 2025 Nov 14, 00:00

Investor Alert: Is the US Stock Market Nearing a Turning Point?

Ava Grace 2025 Nov 14, 00:00

Can the AI Boom Sustain the US Economy? Navigating Deglobalization

Sophia Claire 2025 Nov 14, 00:00

Market Risk: Strong Economy Forces Fed to Be Hawkish

Frances Wang 2025 Nov 13, 16:00

Crypto Price Prediction 2026: Bitcoin (BTC), Ethereum (ETH), Ripple (XRP)

Ghko B 2025 Nov 13, 16:00

What will VOO ETF be in 2040: Is Vanguard S&P 500 ETF a good buy?

Frances Wang 2025 Nov 13, 16:00

Commodity market today: Gold prices are rising, what is XAU/USD prediction?

Frances Wang 2025 Nov 13, 16:00

AI stocks are trending: Qualcomm stock, Nvidia (NVDA), AMD stock

Ghko B 2025 Nov 12, 16:00

VOO performance analysis: What is the VOO ETF performance prediction?

Ghko B 2025 Nov 12, 16:00

Easy stocks for beginners: MSFT stock, AAPL stock, NVIDIA (NASDAQ: NVDA)

Frances Wang 2025 Nov 12, 16:00

Stellar climbs 4% today: Stellar (XLM) Price Prediction for 2025, 2026, 2030

Latest news

Show more
Noah Lee 2025 Nov 14, 13:50

Uniswap Launches Continuous Clearing Auctions (CCA) for Enhanced Token Offerings

Emma Rose 2025 Nov 14, 12:50

Alibaba Explores Deposit Tokens Amid China's Stablecoin Scrutiny

Emma Rose 2025 Nov 14, 11:50

XRP ETF Debut Signals Renewed Altcoin Demand

Ava Grace 2025 Nov 14, 11:00

Pig Butchering Scam: A Growing National Security Threat

Ava Grace 2025 Nov 14, 10:40

ARK Invest Resumes Circle Share Purchases as Stock Dips Below $90

Sophia Claire 2025 Nov 14, 10:30

Bitcoin ETF Outflows Deepen Amidst XRP ETF's Unexpected Success

Emma Rose 2025 Nov 14, 10:10

AI's Power Bottleneck: How Crypto Miners Pivot to Data Centers

Emma Rose 2025 Nov 14, 09:40

Aztec Network Token Launch Sparks Controversy: A Deep Dive into Criticisms and Strategy

Info

Spread

1.50

Spread (%)

0.6447 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Friday

14:31 - 20:59

Monday

14:31-20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

412207087616

Shares Outstanding

1767384632

Earnings Date (Next)

0000-00-00

Div Yield

2026-02-17

Ex-Dividend Date

2026-01-16

Forward annual dividend rate

6.92

Forward annual dividend yield

0.0297

EPS

1.33

Learn more about this instrument

AbbVie AbbVie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 13, 16:00

Which broker is best for bitcoin trading: Cheapest Ways to Buy Bitcoin In 2026

Ghko B 2025 Nov 13, 16:00

Crypto day trading strategy: How to day trade crypto as a beginner?

Ghko B 2025 Nov 13, 16:00

Commodity trading strategy: WTI Oil faces potential decline, what’s next?

Trustpilot